Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoClin Corp (OTC Pink - Limited Information:IMCL.PK)

2.00
Delayed Data
As of Aug 19
 0.00 / 0.00%
Today’s Change
1.10
Today|||52-Week Range
5.60
-60.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$57.7M

Company Description

Immunoclin Corp., engages in immunology research and development. It operates through its subsidiary, Immunoclin Limited, which provides specialized, commercially-focused immunology consulting, testing and assessment, in the context of research and development clinical services. Its products include: MIRA™, GARD™, PRIMALEUKIN™, DACTELLIGENCE™, and GastroWellBeing™. The company was founded on February 8, 2011 and is headquartered in Washington, DC.

Contact Information

Immunoclin Corp.
1800 Wyoming Avenue, NW
Washington District Of Columbia 20009
P:(888) 267-1175
Investor Relations:

Employees

Shareholders

Individual stakeholders100.59%
Mutual fund holders--
Other institutional--

Top Executives

Dorothy H. BrayPresident, Chief Executive Officer & Director
Chad S. JohnsonCOO, Secretary, Director & General Counsel
James Scott MunroCFO, Treasurer & Principal Accounting Officer
Khadija BenlhassanDirector & Chief Scientific Officer